Exact Sciences Corp
NASDAQ:EXAS
Exact Sciences Corp
Inventory
Exact Sciences Corp
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Exact Sciences Corp
NASDAQ:EXAS
|
Inventory
$128.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Inventory
$4.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Inventory
$1.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-1%
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$8.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
24%
|
CAGR 10-Years
11%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Inventory
$813.1m
|
CAGR 3-Years
40%
|
CAGR 5-Years
43%
|
CAGR 10-Years
54%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Inventory
$2.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
41%
|
See Also
What is Exact Sciences Corp's Inventory?
Inventory
128.5m
USD
Based on the financial report for Mar 31, 2024, Exact Sciences Corp's Inventory amounts to 128.5m USD.
What is Exact Sciences Corp's Inventory growth rate?
Inventory CAGR 5Y
24%
Over the last year, the Inventory growth was 4%. The average annual Inventory growth rates for Exact Sciences Corp have been 13% over the past three years , 24% over the past five years .